Tue Jun 17 10:27:22 UTC 2025: Here’s a summary and a news article version of the provided text:

**Summary:**

The article discusses the evolution of clinical trials from their rudimentary beginnings in the 18th century to the sophisticated, regulated process they are today. It highlights the importance of randomization, blinding, and controlled comparisons in ensuring the validity of trial results. A key focus is on the development and increasing importance of clinical trial registries, designed to combat selective reporting of results and ensure transparency. The article concludes by noting the World Health Organization’s updated guidelines requiring comprehensive reporting of trial results within 12 months of completion, emphasizing that even “failed” trials contribute valuable knowledge.

**News Article:**

**WHO Mandates Comprehensive Reporting of Clinical Trial Results, Boosting Transparency**

**New Delhi, June 18, 2025** – The World Health Organization (WHO) has issued new guidelines mandating comprehensive reporting of clinical trial results within 12 months of trial completion, a move lauded by the global medical community as a significant step toward transparency and combating medical misinformation. The guidelines, released in April, address the long-standing problem of selective reporting, where only favorable results are published, leading to biased evidence and wasted resources.

This new guidance requires researchers to make available the final trial protocol, statistical analysis plan, completion status, dates of reporting, participant flow, baseline characteristics, detailed outcome results, harms/adverse events, and declarations of conflict of interest. The guidelines draw inspiration from the CONSORT 2025 reporting standards, aiming to harmonize reporting in journals and registries.

“This change reflects a profound ethical principle: every trial must contribute to scientific knowledge,” stated Dr. C. Aravinda, an academic and public health physician. “A failed trial, transparently reported, is as valuable as a successful one – it prevents duplication, protects patients, and refines research.”

The origins of rigorous clinical trials can be traced back to James Lind’s 1747 experiment on scurvy. Modern clinical trials evolved significantly in the 20th century with the introduction of randomized controlled trials. Now they include a multi-phase validation process from animal testing to multi-center studies before approval. The issue of selective reporting lead to the development of trial registries.

The move builds upon the existing framework of clinical trial registries like ClinicalTrials.gov (U.S.) and the Clinical Trials Registry – India (CTRI), which was launched in 2007 and made mandatory for interventional trials in India by 2009. These registries act as public ledgers, documenting key information about trials from their inception to completion. The CTRI requires investigators to create an account, fill out a structured data set, attach ethics approvals, and submit for verification.

The WHO’s International Clinical Trials Registry Platform (ICTRP), established in 2006, which linked multiple national registries across the globe, has also been working to integrate these updates into a combined ‘Registration and Results Data Set.’

Read More